Key result
The intratubular renin-angiotensin system plays a key role in the pathophysiology of hypertension and serves as a target for pharmacological blockade.
This review highlights the role of the intratubular renin-angiotensin system in hypertension pathophysiology and its response to pharmacological blockade.
Answers are grounded in this paper and cite their sources.
May inform RAS inhibitor choice in hypertension; extends local renal mechanisms but leaves open targeted trial confirmation.
It is well recognized that the renin-angiotensin system plays an important role in the regulation of arterial pressure and sodium homeostasis. Recent years, many studies have shown that local tissue angiotensin II levels are differentially regulated and cannot be explained on the basis of circulating concentrations. All of the components needed for angiotensin II generation are present within the various compartments in the kidney including the renal interstitium and the tubular network. The cascade of the renin-angiotensin system demonstrates three major possible sites for the pharmacological interruption of the renin-angiotensin system: the interaction of renin with its substrate, angiotensinogen, the angiotensin converting enzyme, and angiotensin II type 1 receptors. This brief article will focus on the role of the intratubular renin-angiotensin system in the pathophysiology of hypertension and the responses to the renin-angiotensin system blockade by renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockers.
No takes yet. Share an insight, caveat, or question.
Suzaki et al. (2006) conducted a review in Hypertension. Renin-angiotensin system blockade was evaluated. The intratubular renin-angiotensin system plays a key role in the pathophysiology of hypertension and serves as a target for pharmacological blockade.
Synapse has enriched 10 related papers. Consider them for comparative context: